Are Clinically Insignificant Prostate Cancers Really Insignificant among Korean Men?.
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3349/ymj.2012.53.2.358
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Chan Dong YEOM
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Seung Hwan LEE
			        		
			        		;
		        		
		        		
		        		
			        		Kyung Kgi PARK
			        		
			        		;
		        		
		        		
		        		
			        		Sang Un PARK
			        		
			        		;
		        		
		        		
		        		
			        		Byung Ha CHUNG
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Department of Urology, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Korea. chung646@yuhs.ac
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Original Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Prostate cancer;
			        		
			        		
			        		
				        		gleason score;
			        		
			        		
			        		
				        		prostate;
			        		
			        		
			        		
				        		clinically insignificant
			        		
			        		
	        			
        			
        		
 
        	
            
            	- MeSH:
            	
	        			
	        				
	        				
				        		
					        		Aged;
				        		
			        		
				        		
					        		Humans;
				        		
			        		
				        		
					        		Male;
				        		
			        		
				        		
					        		Middle Aged;
				        		
			        		
				        		
					        		Prostate-Specific Antigen/blood;
				        		
			        		
				        		
					        		Prostatectomy;
				        		
			        		
				        		
					        		Prostatic Neoplasms/blood/*diagnosis/surgery;
				        		
			        		
				        		
					        		Retrospective Studies
				        		
			        		
	        			
	        			
            	
            	
 
            
            
            	- From:Yonsei Medical Journal
	            		
	            		 2012;53(2):358-362
	            	
            	
 
            
            
            	- CountryRepublic of Korea
 
            
            
            	- Language:English
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	PURPOSE: We aimed to determine whether 12 core-extended biopsies of the prostate could predict insignificant prostate cancer (IPCa) in Koreans reliably enough to recommend active surveillance. MATERIALS AND METHODS: Two hundred and ninety-seven patients who underwent radical prostatectomy after 12 core-extended prostate biopsies were retrospectively reviewed. 38 cases (12.8%) were shown to be IPCa. RESULTS: The average age was 65.2 years, serum PSA was 5.49 ng/dL, and the PSA density was 0.11. The Gleason scores (GS) were 6 (3+3) in 31, 5 (3+2) in 4, and 4 (2+2) in 3. After radical prostatectomy, higher GS was given in 16 (42.1%), whereas lower GS was given in 1 case (2.6%), as compared with the GS obtained from biopsy. 11 (28.9%) had GS of 7 (3+4) and 5 (13.2%) had GS of 7 (4+3). 6 in GS 7 (4+3) and 1 in GS 7 (3+4) showed prostate capsule invasion and 1 in GS 7 (4+3) had seminal vesicle invasion. Prostate capsule invasion was observed in 1 with GS 6 (3+3). The rate of inaccuracy of the contemporary Epstein criteria was 42.1%. Only PSA density was a reliable indicator of clinically IPCa (odds ratio=1.384, 95% CI, 1.103 to 2.091). CONCLUSION: Diagnosis of IPCa from a prostate biopsy underestimated the true nature of prostate cancer in as many as 42.1% of Koreans.